{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T14:10:56Z","timestamp":1788012656251,"version":"build-2784847793"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s40123-026-01354-9","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T01:39:02Z","timestamp":1774229942000},"page":"1561-1584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Redefining Dry Eye Disease Management: Emerging Pharmacologic and Device-Based Therapies in the Era of Precision Care: A Narrative Review"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0848-5172","authenticated-orcid":false,"given":"Bharat","family":"Gurnani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0951-7415","authenticated-orcid":false,"given":"Kirandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"issue":"3","key":"1354_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61030460","volume":"61","author":"J Kwon","year":"2025","unstructured":"Kwon J, Moghtader A, Kang C, Bibak Bejandi Z, Shahjahan S, Alzein A, et al. Overview of dry eye disease for primary care physicians. Medicina (Kaunas). 2025;61(3):460. https:\/\/doi.org\/10.3390\/medicina61030460.","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"1354_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40135-013-0009-1","volume":"1","author":"M Uchino","year":"2013","unstructured":"Uchino M, Schaumberg DA. Dry eye disease: impact on quality of life and vision. Curr Ophthalmol Rep. 2013;1(2):51\u20137. https:\/\/doi.org\/10.1007\/s40135-013-0009-1.","journal-title":"Curr Ophthalmol Rep"},{"issue":"5","key":"1354_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3238\/arztebl.2015.0071","volume":"112","author":"EM Messmer","year":"2015","unstructured":"Messmer EM. The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int. 2015;112(5):71\u201381. https:\/\/doi.org\/10.3238\/arztebl.2015.0071.","journal-title":"Dtsch Arztebl Int"},{"issue":"12","key":"1354_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14124147","volume":"14","author":"T Su\u00e1rez-Cort\u00e9s","year":"2025","unstructured":"Su\u00e1rez-Cort\u00e9s T, Herrera I. Emerging age-specific therapeutic approaches for dry eye disease. J Clin Med. 2025;14(12):4147. https:\/\/doi.org\/10.3390\/jcm14124147.","journal-title":"J Clin Med"},{"issue":"4","key":"1354_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/vision8040067","volume":"8","author":"MA Romeo","year":"2024","unstructured":"Romeo MA, Coco G, Taloni A, Carnovale-Scalzo G, Scorcia V, Giannaccare G. Digital applications for videoterminal-associated dry eye disease. Vision (Basel). 2024;8(4):67. https:\/\/doi.org\/10.3390\/vision8040067.","journal-title":"Vision (Basel)"},{"issue":"5","key":"1354_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s40123-025-01129-8","volume":"14","author":"D Lam","year":"2025","unstructured":"Lam D, Chong K, Shih K, Wan KH, Cheng A. Optimizing diagnosis and management of dry eye disease: a practical framework for Hong Kong. Ophthalmol Ther. 2025;14(5):815\u201333. https:\/\/doi.org\/10.1007\/s40123-025-01129-8.","journal-title":"Ophthalmol Ther"},{"key":"1354_CR7","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.2147\/PPA.S518658","volume":"19","author":"D Kirkove","year":"2025","unstructured":"Kirkove D, Durieux N, Allory E, Louis G, Gagnayre R, P\u00e9tr\u00e9 B. Implementation of therapeutic patient education (TPE) in primary care, as perceived by professionals: a narrative review. Patient Prefer Adherence. 2025;19:1681\u201391. https:\/\/doi.org\/10.2147\/PPA.S518658.","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"1354_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"L Jones","year":"2017","unstructured":"Jones L, Downie LE, Korb D, Benitez-Del-Castillo JM, Dana R, Deng SX, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15(3):575\u2013628. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.006.","journal-title":"Ocul Surf"},{"issue":"1","key":"1354_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/01.icu.0000512373.81749.b7","volume":"27","author":"MS Milner","year":"2017","unstructured":"Milner MS, Beckman KA, Luchs JI, Allen QB, Awdeh RM, Berdahl J, et al. Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment. Curr Opin Ophthalmol. 2017;27(1):3\u201347. https:\/\/doi.org\/10.1097\/01.icu.0000512373.81749.b7.","journal-title":"Curr Opin Ophthalmol"},{"issue":"7","key":"1354_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ph18070994","volume":"18","author":"J Betz","year":"2025","unstructured":"Betz J, Galor A. Navigating the dry eye therapeutic puzzle: a mechanism-based overview of current treatments. Pharmaceuticals (Basel). 2025;18(7):994. https:\/\/doi.org\/10.3390\/ph18070994.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"1354_CR11","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.4103\/IJO.IJO_481_23","volume":"71","author":"RP Kaur","year":"2023","unstructured":"Kaur RP, Gurnani B, Kaur K. Intricate insights into immune response in dry eye disease. Indian J Ophthalmol. 2023;71(4):1248\u201355. https:\/\/doi.org\/10.4103\/IJO.IJO_481_23.","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"1354_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40265-016-0681-1","volume":"77","author":"GM Keating","year":"2017","unstructured":"Keating GM. Lifitegrast ophthalmic solution 5%: a review in dry eye disease. Drugs. 2017;77(2):201\u20138. https:\/\/doi.org\/10.1007\/s40265-016-0681-1.","journal-title":"Drugs"},{"issue":"11","key":"1354_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ph18111682","volume":"18","author":"M Sarnat-Kucharczyk","year":"2025","unstructured":"Sarnat-Kucharczyk M, Nowak M, Mrukwa-Kominek E. Long-term efficacy and safety of 0.1% cyclosporine A cationic emulsion in advanced dry eye disease: a 24-month retrospective study. Pharmaceuticals (Basel). 2025;18(11):1682. https:\/\/doi.org\/10.3390\/ph18111682.","journal-title":"Pharmaceuticals (Basel)"},{"key":"1354_CR14","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.2147\/OPTH.S259331","volume":"14","author":"V Burade","year":"2020","unstructured":"Burade V, Zalawadia R, Patel A, Ogundele A. Preclinical efficacy comparison of cyclosporine ophthalmic solution 0.09% vs. cyclosporine ophthalmic emulsion 0.05% vs. ciclosporin ophthalmic emulsion 0.1% in a NOD mouse model of dry eye disease. Clin Ophthalmol. 2020;14:2747\u201355. https:\/\/doi.org\/10.2147\/OPTH.S259331.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"1354_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/07853890.2022.2157477","volume":"55","author":"J Sheppard","year":"2023","unstructured":"Sheppard J, Shen Lee B, Periman LM. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists. Ann Med. 2023;55(1):241\u201352. https:\/\/doi.org\/10.1080\/07853890.2022.2157477.","journal-title":"Ann Med"},{"issue":"1","key":"1354_CR16","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.4103\/jpbs.jpbs_1451_24","volume":"17","author":"D Swathi","year":"2025","unstructured":"Swathi D, Sailo JL, Ausare SS, Bhattacharjee D, Buvariya S, Dolker T, et al. Management strategies for xerostomia in patients with Sj\u00f6gren\u2019s syndrome: a comprehensive review. J Pharm Bioallied Sci. 2025;17(1):S74\u20136. https:\/\/doi.org\/10.4103\/jpbs.jpbs_1451_24.","journal-title":"J Pharm Bioallied Sci"},{"issue":"14","key":"1354_CR17","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s40265-022-01782-4","volume":"82","author":"JE Frampton","year":"2022","unstructured":"Frampton JE. Varenicline solution nasal spray: a review in dry eye disease. Drugs. 2022;82(14):1481\u20138. https:\/\/doi.org\/10.1007\/s40265-022-01782-4.","journal-title":"Drugs"},{"issue":"10","key":"1354_CR18","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1097\/ICO.0000000000002941","volume":"41","author":"D Wirta","year":"2022","unstructured":"Wirta D, Torkildsen GL, Boehmer B, Hollander DA, Bendert E, Zeng L, et al. ONSET-1 phase 2b randomized trial to evaluate the safety and efficacy of OC-01 (varenicline solution) nasal spray on signs and symptoms of dry eye disease. Cornea. 2022;41(10):1207\u201316. https:\/\/doi.org\/10.1097\/ICO.0000000000002941.","journal-title":"Cornea"},{"key":"1354_CR19","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2147\/OPTH.S69486","volume":"9","author":"S Koh","year":"2015","unstructured":"Koh S. Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes. Clin Ophthalmol. 2015;9:865\u201372. https:\/\/doi.org\/10.2147\/OPTH.S69486.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"1354_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63784-4","volume":"14","author":"Y Jin","year":"2024","unstructured":"Jin Y, Seo KY, Kim SW. Comparing two mucin secretagogues for the treatment of dry eye disease: a prospective randomized crossover trial. Sci Rep. 2024;14(1):13306. https:\/\/doi.org\/10.1038\/s41598-024-63784-4.","journal-title":"Sci Rep"},{"issue":"4","key":"1354_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s40265-024-02016-5","volume":"84","author":"A Zhuang-Yan","year":"2024","unstructured":"Zhuang-Yan A, Syed YY. Perfluorohexyloctane ophthalmic solution: a review in dry eye disease. Drugs. 2024;84(4):441\u20138. https:\/\/doi.org\/10.1007\/s40265-024-02016-5.","journal-title":"Drugs"},{"key":"1354_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2023.100704","volume":"98","author":"J Vittitow","year":"2023","unstructured":"Vittitow J, Kissling R, DeCory H, Borchman D. In vitro inhibition of evaporation with perfluorohexyloctane, an eye drop for dry eye disease. Curr Ther Res Clin Exp. 2023;98:100704. https:\/\/doi.org\/10.1016\/j.curtheres.2023.100704.","journal-title":"Curr Ther Res Clin Exp"},{"issue":"29","key":"1354_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000043026","volume":"104","author":"R Munsab","year":"2025","unstructured":"Munsab R, Zafar R, Fatima A, Taj J, Usman M, Anjum MU, et al. Efficacy and safety of perfluorohexyloctane (PFHO) in patients with dry eye disease (DED) due to meibomian gland dysfunction (MGD): systematic review and meta-analysis. Medicine (Baltimore). 2025;104(29):e43026. https:\/\/doi.org\/10.1097\/MD.0000000000043026.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"1354_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2023.101845","volume":"46","author":"AJ Mateo-Orobia","year":"2023","unstructured":"Mateo-Orobia AJ, Del Prado Sanz E, Blasco-Mart\u00ednez A, Pablo-J\u00falvez LE, Farrant S, Chiambaretta F. Efficacy of artificial tears containing trehalose and hyaluronic acid for dry eye disease in women aged 42-54 versus\u00a0\u2265\u00a055\u00a0years. Contact Lens Anterior Eye. 2023;46(4):101845. https:\/\/doi.org\/10.1016\/j.clae.2023.101845.","journal-title":"Contact Lens Anterior Eye"},{"key":"1354_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1430785","volume":"11","author":"CZ He","year":"2024","unstructured":"He CZ, Zeng ZJ, Liu JQ, Qiu Q, He Y. Autologous serum eye drops for patients with dry eye disease: a systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne). 2024;11:1430785. https:\/\/doi.org\/10.3389\/fmed.2024.1430785.","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"1354_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13092316","volume":"13","author":"AL Mederle","year":"2025","unstructured":"Mederle AL, Andrei D, Ghenciu LA, Stoicescu ER, Iacob R, Ha\u0163egan OA. Comparative efficacy of platelet-rich plasma, autologous serum, and artificial tears in dry eye disease: a systematic review and meta-analysis. Biomedicines. 2025;13(9):2316. https:\/\/doi.org\/10.3390\/biomedicines13092316.","journal-title":"Biomedicines"},{"key":"1354_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1500160","volume":"11","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li N, Ge Z, Li F. Blood component therapy for dry eye disease: a systematic review and network meta-analysis. Front Med (Lausanne). 2024;11:1500160. https:\/\/doi.org\/10.3389\/fmed.2024.1500160.","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"1354_CR28","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/ICO.0000000000000756","volume":"35","author":"YJ Kim","year":"2016","unstructured":"Kim YJ, Ryu JS, Park SY, Lee HJ, Ko JH, Kim MK, et al. Comparison of topical application of TSG-6, cyclosporine, and prednisolone for treating dry eye. Cornea. 2016;35(4):536\u201342. https:\/\/doi.org\/10.1097\/ICO.0000000000000756.","journal-title":"Cornea"},{"issue":"9","key":"1354_CR29","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1097\/ICO.0000000000003418","volume":"43","author":"EE Protzko","year":"2024","unstructured":"Protzko EE, Segal BA, Korenfeld MS, Kr\u00f6sser S, Vittitow JL. Long-term safety and efficacy of perfluorohexyloctane ophthalmic solution for the treatment of patients with dry eye disease: the KALAHARI study. Cornea. 2024;43(9):1100\u20137. https:\/\/doi.org\/10.1097\/ICO.0000000000003418.","journal-title":"Cornea"},{"issue":"8","key":"1354_CR30","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s40123-025-01187-y","volume":"14","author":"D Ben Ephraim Noyman","year":"2025","unstructured":"Ben Ephraim Noyman D, Chan CC, Teichman JC, Arbel I, Yosefi O, Lapid-Gortzak R, et al. Dry eye disease management via technological methods: a systematic review and network meta-analysis. Ophthalmol Ther. 2025;14(8):1917\u201354. https:\/\/doi.org\/10.1007\/s40123-025-01187-y.","journal-title":"Ophthalmol Ther"},{"issue":"6","key":"1354_CR31","doi-asserted-by":"publisher","first-page":"BIO1","DOI":"10.1167\/iovs.17-21709","volume":"58","author":"NS Roy","year":"2017","unstructured":"Roy NS, Wei Y, Kuklinski E, Asbell PA. The growing need for validated biomarkers and endpoints for dry eye clinical research. Invest Ophthalmol Vis Sci. 2017;58(6):BIO1\u201319. https:\/\/doi.org\/10.1167\/iovs.17-21709.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1354_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/OPTH.S498869","volume":"19","author":"KY Chen","year":"2025","unstructured":"Chen KY, Chan HC, Chan CM. Is thermal pulsation therapy effective for dry eyes before and after cataract surgery? A systematic review and meta-analysis. Clin Ophthalmol. 2025;19:19\u201333. https:\/\/doi.org\/10.2147\/OPTH.S498869.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"1354_CR33","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/ICO.0000000000002837","volume":"41","author":"PK Gupta","year":"2022","unstructured":"Gupta PK, Holland EJ, Hovanesian J, Loh J, Jackson MA, Karpecki PM, et al. TearCare for the treatment of meibomian gland dysfunction in adult patients with dry eye disease: a masked randomized controlled trial. Cornea. 2022;41(4):417\u201326. https:\/\/doi.org\/10.1097\/ICO.0000000000002837.","journal-title":"Cornea"},{"key":"1354_CR34","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.2147\/OPTH.S368319","volume":"16","author":"EJ Holland","year":"2022","unstructured":"Holland EJ, Loh J, Bloomenstein M, Thompson V, Wirta D, Dhamdhere K. A comparison of TearCare and LipiFlow systems in reducing dry eye disease symptoms associated with meibomian gland disease. Clin Ophthalmol. 2022;16:2861\u201371. https:\/\/doi.org\/10.2147\/OPTH.S368319.","journal-title":"Clin Ophthalmol"},{"issue":"8","key":"1354_CR35","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s40123-024-00976-1","volume":"13","author":"CA Blackie","year":"2024","unstructured":"Blackie CA, Murakami D, Donnenfeld E, Oliff HS. Vectored thermal pulsation as a treatment for meibomian gland dysfunction: a review spanning 15 years. Ophthalmol Ther. 2024;13(8):2083\u2013123. https:\/\/doi.org\/10.1007\/s40123-024-00976-1.","journal-title":"Ophthalmol Ther"},{"key":"1354_CR36","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.2147\/OPTH.S349596","volume":"16","author":"B Barbosa Ribeiro","year":"2022","unstructured":"Barbosa Ribeiro B, Marta A, Ponces Ramalh\u00e3o J, Marques JH, Barbosa I. Pulsed light therapy in the management of dry eye disease: current perspectives. Clin Ophthalmol. 2022;16:3883\u201393. https:\/\/doi.org\/10.2147\/OPTH.S349596.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"1354_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00417-020-04834-1","volume":"259","author":"X Leng","year":"2021","unstructured":"Leng X, Shi M, Liu X, Cui J, Sun H, Lu X. Intense pulsed light for meibomian gland dysfunction: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2021;259(1):1\u201310. https:\/\/doi.org\/10.1007\/s00417-020-04834-1.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"1354_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.70357","volume":"24","author":"S Menashe","year":"2025","unstructured":"Menashe S, Bermejo IG, Lois M, Molinari LM, Reig MI. Effective treatment of rosacea and telangiectasias using IPL. J Cosmet Dermatol. 2025;24(8):e70357. https:\/\/doi.org\/10.1111\/jocd.70357.","journal-title":"J Cosmet Dermatol"},{"key":"1354_CR39","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.2147\/OPTH.S284622","volume":"15","author":"MD Yu","year":"2021","unstructured":"Yu MD, Park JK, Kossler AL. Stimulating tear production: spotlight on neurostimulation. Clin Ophthalmol. 2021;15:4219\u201326. https:\/\/doi.org\/10.2147\/OPTH.S284622.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"1354_CR40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s40123-022-00616-6","volume":"12","author":"Z Li","year":"2023","unstructured":"Li Z, Wang X, Li X. Effectiveness of intranasal tear neurostimulation for treatment of dry eye disease: a meta-analysis. Ophthalmol Ther. 2023;12(1):389\u2013400. https:\/\/doi.org\/10.1007\/s40123-022-00616-6.","journal-title":"Ophthalmol Ther"},{"issue":"12","key":"1354_CR41","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.9.12.23","volume":"9","author":"MH Ji","year":"2020","unstructured":"Ji MH, Moshfeghi DM, Periman L, Kading D, Matossian C, Walman G, et al. Novel extranasal tear stimulation: pivotal study results. Trans Vis Sci Technol. 2020;9(12):23. https:\/\/doi.org\/10.1167\/tvst.9.12.23.","journal-title":"Trans Vis Sci Technol"},{"issue":"3","key":"1354_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030990","volume":"15","author":"H Mondal","year":"2023","unstructured":"Mondal H, Kim HJ, Mohanto N, Jee JP. A review on dry eye disease treatment: recent progress, diagnostics, and future perspectives. Pharmaceutics. 2023;15(3):990. https:\/\/doi.org\/10.3390\/pharmaceutics15030990.","journal-title":"Pharmaceutics"},{"key":"1354_CR43","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.2147\/OPTH.S118409","volume":"10","author":"A Farkouh","year":"2016","unstructured":"Farkouh A, Frigo P, Czejka M. Systemic side effects of eye drops: a pharmacokinetic perspective. Clin Ophthalmol. 2016;10:2433\u201341. https:\/\/doi.org\/10.2147\/OPTH.S118409.","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"1354_CR44","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/ACI.0000000000000841","volume":"22","author":"N Erdinest","year":"2022","unstructured":"Erdinest N, Pincovich S, London N, Solomon A. Neurostimulation for dry eye disease. Curr Opin Allergy Clin Immunol. 2022;22(5):328\u201334. https:\/\/doi.org\/10.1097\/ACI.0000000000000841.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"9","key":"1354_CR45","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/jop.2023.0064","volume":"39","author":"L Ajouz","year":"2023","unstructured":"Ajouz L, Nguyen A, Zhao C, Robinson MR, Nichols KK. Exploring signs and symptoms associated with meibomian gland dysfunction for use as clinical trial endpoints. J Ocul Pharmacol Ther. 2023;39(9):611\u201321. https:\/\/doi.org\/10.1089\/jop.2023.0064.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"1354_CR46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/YCT.0000000000000990","volume":"40","author":"MK Cortright","year":"2024","unstructured":"Cortright MK, Bluhm R, Achtyes ED, McCright AM, Cabrera LY. Perceived barriers to using neurostimulation: a national survey of psychiatrists, patients, caregivers, and the general public. J ECT. 2024;40(2):111\u20137. https:\/\/doi.org\/10.1097\/YCT.0000000000000990.","journal-title":"J ECT"},{"issue":"7","key":"1354_CR47","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.drudis.2015.01.013","volume":"20","author":"VK Yellepeddi","year":"2015","unstructured":"Yellepeddi VK, Sheshala R, McMillan H, Gujral C, Jones D, Raghu Raj Singh T. Punctal plug: a medical device to treat dry eye syndrome and for sustained drug delivery to the eye. Drug Discov Today. 2015;20(7):884\u20139. https:\/\/doi.org\/10.1016\/j.drudis.2015.01.013.","journal-title":"Drug Discov Today"},{"issue":"6","key":"1354_CR48","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.ophtha.2019.01.024","volume":"126","author":"DL Wirta","year":"2019","unstructured":"Wirta DL, Torkildsen GL, Moreira HR, Lonsdale JD, Ciolino JB, Jentsch G, et al. A clinical phase II study to assess efficacy, safety, and tolerability of waterfree cyclosporine formulation for treatment of dry eye disease. Ophthalmology. 2019;126(6):792\u2013800. https:\/\/doi.org\/10.1016\/j.ophtha.2019.01.024.","journal-title":"Ophthalmology"},{"issue":"6","key":"1354_CR49","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1177\/08853282251369229","volume":"40","author":"NE Subhash","year":"2026","unstructured":"Subhash NE, Prabhu M, Hazarika M, S S, Bhandary SV, Guru BR. Advances in the management of ocular anterior segment diseases using biomaterials-based drug delivery systems. J Biomater Appl. 2026;40(6):666\u201389. https:\/\/doi.org\/10.1177\/08853282251369229.","journal-title":"J Biomater Appl"},{"issue":"4","key":"1354_CR50","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/ICO.0000000000003097","volume":"42","author":"E Yeu","year":"2023","unstructured":"Yeu E, Wirta DL, Karpecki P, Baba SN, Holdbrook M, Saturn I Study Group. Lotilaner ophthalmic solution, 0.25%, for the treatment of Demodex blepharitis: results of a prospective, randomized, vehicle-controlled, double-masked, pivotal trial (Saturn-1). Cornea. 2023;42(4):435\u201343. https:\/\/doi.org\/10.1097\/ICO.0000000000003097.","journal-title":"Cornea"},{"issue":"23","key":"1354_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14238406","volume":"14","author":"CC Chien","year":"2025","unstructured":"Chien CC, Chang YM, Liang CM, Chien KH, Tai MC, Lin TY, et al. Therapeutic outcomes of combined eyelid hygiene, intense pulsed light, and meibomian gland expression in meibomian gland dysfunction. J Clin Med. 2025;14(23):8406. https:\/\/doi.org\/10.3390\/jcm14238406.","journal-title":"J Clin Med"},{"key":"1354_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.826530","volume":"8","author":"Y Wu","year":"2022","unstructured":"Wu Y, Wang C, Wang X, Mou Y, Yuan K, Huang X, et al. Advances in dry eye disease examination techniques. Front Med (Lausanne). 2022;8:826530. https:\/\/doi.org\/10.3389\/fmed.2021.826530.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"1354_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics16010126","volume":"16","author":"A Macri","year":"2026","unstructured":"Macri A, Tarallo M, Iester M. Imaging approaches for the diagnosis of dry eye: a review. Diagnostics. 2026;16(1):126. https:\/\/doi.org\/10.3390\/diagnostics16010126.","journal-title":"Diagnostics"},{"issue":"7","key":"1354_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/life13071425","volume":"13","author":"A De Luca","year":"2023","unstructured":"De Luca A, Ferraro A, De Gregorio C, Laborante M, Coassin M, Sgrulletta R, et al. Promising high-tech devices in dry eye disease diagnosis. Life (Basel). 2023;13(7):1425. https:\/\/doi.org\/10.3390\/life13071425.","journal-title":"Life (Basel)"},{"issue":"1","key":"1354_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-025-04234-6","volume":"20","author":"RD Bairagi","year":"2025","unstructured":"Bairagi RD, Reon RR, Hasan MM, Sarker S, Debnath D, Rahman MT, et al. Ocular drug delivery systems based on nanotechnology: a comprehensive review for the treatment of eye diseases. Discov Nano. 2025;20(1):75. https:\/\/doi.org\/10.1186\/s11671-025-04234-6.","journal-title":"Discov Nano"},{"issue":"1","key":"1354_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s40662-019-0172-z","volume":"7","author":"CW McMonnies","year":"2020","unstructured":"McMonnies CW. Aqueous deficiency is a contributor to evaporation-related dry eye disease. Eye Vis. 2020;7(1):6. https:\/\/doi.org\/10.1186\/s40662-019-0172-z.","journal-title":"Eye Vis"},{"key":"1354_CR57","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2147\/OPTH.S402556","volume":"17","author":"C Nilsen","year":"2023","unstructured":"Nilsen C, Graae Jensen P, Gundersen M, Utheim \u00d8A, Gjerdrum B, Gundersen KG, et al. The significance of inter-eye osmolarity difference in dry eye diagnostics. Clin Ophthalmol. 2023;17:829\u201335. https:\/\/doi.org\/10.2147\/OPTH.S402556.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"1354_CR58","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1167\/iovs.10-6997f","volume":"52","author":"A Tomlinson","year":"2011","unstructured":"Tomlinson A, Bron AJ, Korb DR, Amano S, Paugh JR, Pearce EI, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):2006\u201349. https:\/\/doi.org\/10.1167\/iovs.10-6997f.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1354_CR59","doi-asserted-by":"publisher","first-page":"223","DOI":"10.34172\/jcvtr.2023.31844","volume":"15","author":"T Akbari","year":"2023","unstructured":"Akbari T, Kazemi Fard T, Fadaei R, Rostami R, Moradi N, Movahedi M, et al. Evaluation of MMP-9, IL-6, TNF-\u03b1 levels and peripheral blood mononuclear cells genes expression of MMP-9 and TIMP-1 in Iranian patients with coronary artery disease. J Cardiovasc Thorac Res. 2023;15(4):223\u201330. https:\/\/doi.org\/10.34172\/jcvtr.2023.31844.","journal-title":"J Cardiovasc Thorac Res"},{"issue":"1","key":"1354_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-01602-5","volume":"8","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wang J, Zong H, Singla RK, Ullah A, Liu X, et al. The comprehensive clinical benefits of digital phenotyping: from broad adoption to full impact. NPJ Digit Med. 2025;8(1):196. https:\/\/doi.org\/10.1038\/s41746-025-01602-5.","journal-title":"NPJ Digit Med"},{"issue":"2","key":"1354_CR61","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jtos.2015.10.004","volume":"14","author":"NL Lanza","year":"2016","unstructured":"Lanza NL, Valenzuela F, Perez VL, Galor A. The matrix metalloproteinase 9 point-of-care test in dry eye. Ocul Surf. 2016;14(2):189\u201395. https:\/\/doi.org\/10.1016\/j.jtos.2015.10.004.","journal-title":"Ocul Surf"},{"issue":"2","key":"1354_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e13323","volume":"9","author":"A Bodaghi","year":"2023","unstructured":"Bodaghi A, Fattahi N, Ramazani A. Biomarkers: promising and valuable tools towards diagnosis, prognosis and treatment of COVID-19 and other diseases. Heliyon. 2023;9(2):e13323. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13323.","journal-title":"Heliyon"},{"issue":"12","key":"1354_CR63","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.50276","volume":"15","author":"A K\u0131l\u0131\u00e7\u00e7\u0131o\u011flu","year":"2023","unstructured":"K\u0131l\u0131\u00e7\u00e7\u0131o\u011flu A, Oncel D, Celebi ARC. Autoimmune disease-related dry eye diseases and their placement under the revised classification systems: an update. Cureus. 2023;15(12):e50276. https:\/\/doi.org\/10.7759\/cureus.50276.","journal-title":"Cureus"},{"issue":"7","key":"1354_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/life12071086","volume":"12","author":"KL Peng","year":"2022","unstructured":"Peng KL, Chiu CJ, Tuan HI, Lee YC, Hsu PS, Chen JL. Combination treatment of intense pulsed light therapy and meibomian gland expression for evaporative dry eye. Life Basel. 2022;12(7):1086. https:\/\/doi.org\/10.3390\/life12071086.","journal-title":"Life Basel"},{"issue":"2","key":"1354_CR65","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2500\/ar.2016.7.0158","volume":"7","author":"W Carr","year":"2016","unstructured":"Carr W, Schaeffer J, Donnenfeld E. Treating allergic conjunctivitis: a once-daily medication that provides 24-hour symptom relief. Allergy Rhinol Providence. 2016;7(2):107\u201314. https:\/\/doi.org\/10.2500\/ar.2016.7.0158.","journal-title":"Allergy Rhinol Providence"},{"issue":"1","key":"1354_CR66","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s0149-2918(03)90011-7","volume":"25","author":"M Backonja","year":"2003","unstructured":"Backonja M, Glanzman RL. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther. 2003;25(1):81\u2013104. https:\/\/doi.org\/10.1016\/s0149-2918(03)90011-7.","journal-title":"Clin Ther"},{"key":"1354_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2021.669869","volume":"3","author":"A Babel","year":"2021","unstructured":"Babel A, Taneja R, Mondello Malvestiti F, Monaco A, Donde S. Artificial intelligence solutions to increase medication adherence in patients with non-communicable diseases. Front Digit Health. 2021;3:669869. https:\/\/doi.org\/10.3389\/fdgth.2021.669869.","journal-title":"Front Digit Health"},{"key":"1354_CR68","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2147\/OPTH.S228838","volume":"14","author":"B Shen Lee","year":"2020","unstructured":"Shen Lee B, Kabat AG, Bacharach J, Karpecki P, Luchs J. Managing dry eye disease and facilitating realistic patient expectations: a review and appraisal of current therapies. Clin Ophthalmol. 2020;14:119\u201326. https:\/\/doi.org\/10.2147\/OPTH.S228838.","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"1354_CR69","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s40123-025-01166-3","volume":"14","author":"N Cheong","year":"2025","unstructured":"Cheong N, Ang JH, Kaya C, Kumar A, Lam SSW, Tong L. Symptomology and impact of dry eye disease: a patient and physician perspective. Ophthalmol Ther. 2025;14(7):1357\u201368. https:\/\/doi.org\/10.1007\/s40123-025-01166-3.","journal-title":"Ophthalmol Ther"},{"key":"1354_CR70","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2147\/OPTH.S226168","volume":"13","author":"DE White","year":"2019","unstructured":"White DE, Zhao Y, Ogundele A, Fulcher N, Acs A, Moore-Schiltz L, et al. Real-world treatment patterns of cyclosporine ophthalmic emulsion and lifitegrast ophthalmic solution among patients with dry eye. Clin Ophthalmol. 2019;13:2285\u201392. https:\/\/doi.org\/10.2147\/OPTH.S226168.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"1354_CR71","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4103\/1817-1737.140120","volume":"9","author":"AA Alangari","year":"2014","unstructured":"Alangari AA. Corticosteroids in the treatment of acute asthma. Ann Thorac Med. 2014;9(4):187\u201392. https:\/\/doi.org\/10.4103\/1817-1737.140120.","journal-title":"Ann Thorac Med"},{"key":"1354_CR72","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.2147\/OPTH.S321591","volume":"15","author":"Z Al-Mohtaseb","year":"2021","unstructured":"Al-Mohtaseb Z, Schachter S, Shen Lee B, Garlich J, Trattler W. The relationship between dry eye disease and digital screen use. Clin Ophthalmol. 2021;15:3811\u201320. https:\/\/doi.org\/10.2147\/OPTH.S321591.","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"1354_CR73","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3733\/ca.v065n03p106","volume":"65","author":"AM Zivkovic","year":"2011","unstructured":"Zivkovic AM, Telis N, German JB, Hammock BD. Dietary omega-3 fatty acids aid in the modulation of inflammation and metabolic health. Calif Agric. 2011;65(3):106\u201311. https:\/\/doi.org\/10.3733\/ca.v065n03p106.","journal-title":"Calif Agric"},{"issue":"12","key":"1354_CR74","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.4103\/IJO.IJO_1457_23","volume":"71","author":"L Zhang","year":"2023","unstructured":"Zhang L, Wang J, Gao Y. Eyelid cleaning: methods, tools, and clinical applications. Indian J Ophthalmol. 2023;71(12):3607\u201314. https:\/\/doi.org\/10.4103\/IJO.IJO_1457_23.","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"1354_CR75","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1007\/s40123-023-00736-7","volume":"12","author":"AA Tovar","year":"2023","unstructured":"Tovar AA, Frankel ST, Galor A, Sabater AL. Living with dry eye disease and its effects on quality of life: patient, optometrist, and ophthalmologist perspectives. Ophthalmol Ther. 2023;12(5):2219\u201326. https:\/\/doi.org\/10.1007\/s40123-023-00736-7.","journal-title":"Ophthalmol Ther"},{"issue":"5","key":"1354_CR76","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s40123-023-00730-z","volume":"12","author":"L Quaranta","year":"2023","unstructured":"Quaranta L, Novella A, Tettamanti M, Pasina L, Weinreb RN, Nobili A. Adherence and persistence to medical therapy in glaucoma: an overview. Ophthalmol Ther. 2023;12(5):2227\u201340. https:\/\/doi.org\/10.1007\/s40123-023-00730-z.","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"1354_CR77","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1177\/11206721221141481","volume":"33","author":"EM Messmer","year":"2023","unstructured":"Messmer EM, Ahmad S, Benitez Del Castillo JM, Mrukwa-Kominek E, Rolando M, Vitovska O, et al. Management of inflammation in dry eye disease: recommendations from a European panel of experts. Eur J Ophthalmol. 2023;33(3):1294\u2013307. https:\/\/doi.org\/10.1177\/11206721221141481.","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"1354_CR78","doi-asserted-by":"publisher","first-page":"550","DOI":"10.18553\/jmcp.2020.26.4.550","volume":"26","author":"Y Peng","year":"2020","unstructured":"Peng Y, Wang H, Fang Q, Xie L, Shu L, Sun W, et al. Effectiveness of mobile applications on medication adherence in adults with chronic diseases: a systematic review and meta-analysis. J Manag Care Spec Pharm. 2020;26(4):550\u201361. https:\/\/doi.org\/10.18553\/jmcp.2020.26.4.550.","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"1354_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-02053-8","volume":"8","author":"Z Xu","year":"2025","unstructured":"Xu Z, Shen J, Jiang M, Wang Y, Sun Y, Lu F, et al. A smartphone-based blink training application for alleviating dry eye signs and symptoms. NPJ Digit Med. 2025;8(1):703. https:\/\/doi.org\/10.1038\/s41746-025-02053-8.","journal-title":"NPJ Digit Med"},{"issue":"11","key":"1354_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10112293","volume":"10","author":"K Bouabida","year":"2022","unstructured":"Bouabida K, Lebouch\u00e9 B, Pomey MP. Telehealth and COVID-19 pandemic: an overview of the telehealth use, advantages, challenges, and opportunities during COVID-19 pandemic. Healthcare. 2022;10(11):2293. https:\/\/doi.org\/10.3390\/healthcare10112293.","journal-title":"Healthcare"},{"key":"1354_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.830986","volume":"9","author":"H Yu","year":"2022","unstructured":"Yu H, Zeng W, Xu M, Wu W, Feng Y. Experience of dry eye patients with anxiety and depression: a qualitative study. Front Med (Lausanne). 2022;9:830986. https:\/\/doi.org\/10.3389\/fmed.2022.830986.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"1354_CR82","doi-asserted-by":"publisher","DOI":"10.2196\/33518","volume":"10","author":"VC Willis","year":"2022","unstructured":"Willis VC, Thomas Craig KJ, Jabbarpour Y, Scheufele EL, Arriaga YE, Ajinkya M, et al. Digital health interventions to enhance prevention in primary care: scoping review. JMIR Med Inform. 2022;10(1):e33518. https:\/\/doi.org\/10.2196\/33518.","journal-title":"JMIR Med Inform"},{"issue":"5","key":"1354_CR83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012419.pub2","volume":"5","author":"AJ Cross","year":"2020","unstructured":"Cross AJ, Elliott RA, Petrie K, Kuruvilla L, George J. Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications. Cochrane Database Syst Rev. 2020;5(5):CD012419. https:\/\/doi.org\/10.1002\/14651858.CD012419.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"1354_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-9-111","volume":"9","author":"L Abetz","year":"2011","unstructured":"Abetz L, Rajagopalan K, Mertzanis P, Begley C, Barnes R, Chalmers R, et al. Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients. Health Qual Life Outcomes. 2011;9(8):111. https:\/\/doi.org\/10.1186\/1477-7525-9-111.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"1354_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s13584-021-00459-9","volume":"10","author":"S Edgman-Levitan","year":"2021","unstructured":"Edgman-Levitan S, Schoenbaum SC. Patient-centered care: achieving higher quality by designing care through the patient\u2019s eyes. Isr J Health Policy Res. 2021;10(1):21. https:\/\/doi.org\/10.1186\/s13584-021-00459-9.","journal-title":"Isr J Health Policy Res"},{"issue":"1","key":"1354_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-025-13598-5","volume":"25","author":"C Pozzan","year":"2025","unstructured":"Pozzan C, Tiso A, Pamich C, Verbano C. Sustainable care quality improvement: a scoping literature review of performance measurement in lean healthcare implementations. BMC Health Serv Res. 2025;25(1):1452. https:\/\/doi.org\/10.1186\/s12913-025-13598-5.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"1354_CR87","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/aos.16802","volume":"103","author":"N Peira","year":"2025","unstructured":"Peira N, Ali EM, Mod\u00e9n NK, Fjellgren E, Lennmarken C, Hultcrantz M. Effectiveness and safety of intense pulsed light therapy for dry eye symptoms due to meibomian gland dysfunction-a systematic review and meta-analysis. Acta Ophthalmol. 2025;103(4):371\u20139. https:\/\/doi.org\/10.1111\/aos.16802.","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"1354_CR88","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1007\/s40123-025-01251-7","volume":"14","author":"G Coco","year":"2025","unstructured":"Coco G, Messmer EM, Starr CE, Pereira-Gomes JA, Lazreg S, Budimlija N, et al. A practical approach for optimizing ocular surface status before cataract surgery to improve visual outcomes and reduce the risk of postoperative dry eye. Ophthalmol Ther. 2025;14(11):2697\u2013733. https:\/\/doi.org\/10.1007\/s40123-025-01251-7.","journal-title":"Ophthalmol Ther"},{"issue":"2","key":"1354_CR89","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5114\/ceji.2016.60995","volume":"41","author":"AM Ambroziak","year":"2016","unstructured":"Ambroziak AM, Szaflik J, Szaflik JP, Ambroziak M, Witkiewicz J, Skopi\u0144ski P. Immunomodulation on the ocular surface: a review. Cent Eur J Immunol. 2016;41(2):195\u2013208. https:\/\/doi.org\/10.5114\/ceji.2016.60995.","journal-title":"Cent Eur J Immunol"},{"issue":"1","key":"1354_CR90","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bj.2021.08.010","volume":"45","author":"TJ Foutz","year":"2022","unstructured":"Foutz TJ, Wong M. Brain stimulation treatments in epilepsy: basic mechanisms and clinical advances. Biomed J. 2022;45(1):27\u201337. https:\/\/doi.org\/10.1016\/j.bj.2021.08.010.","journal-title":"Biomed J"},{"issue":"2","key":"1354_CR91","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.35077","volume":"15","author":"V Kandi","year":"2023","unstructured":"Kandi V, Vadakedath S. Clinical trials and clinical research: a comprehensive review. Cureus. 2023;15(2):e35077. https:\/\/doi.org\/10.7759\/cureus.35077.","journal-title":"Cureus"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01354-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01354-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01354-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:08:38Z","timestamp":1778749718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01354-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":91,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1354"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01354-9","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"3 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Bharat Gurnani is an Editorial Board member of\n                      Ophthalmology and Therapy\n                      . Bharat Gurnani was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Kirandeep Kaur has nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}